You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenoviral

Showing 1 - 25 of 332
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ebola Sudan Virus Disease Trial in Siaya, Kampala (cAD3-Sudan Ebolavirus Vaccine, Placebo)

Not yet recruiting
  • Ebola Sudan Virus Disease
  • cAD3-Sudan Ebolavirus Vaccine
  • Placebo
  • Siaya, Kenya
  • +1 more
Sep 7, 2023

Marburg Virus Disease Trial in Siaya, Kampala (cAd3-Marburg vaccine, Placebo)

Not yet recruiting
  • Marburg Virus Disease
  • cAd3-Marburg vaccine
  • Placebo
  • Siaya, Kenya
  • +1 more
Apr 17, 2023

COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))

Completed
  • COVID-19
  • hAd5-S-Fusion+N-ETSD
  • Placebo (0.9% (w/v) saline)
  • Newport Beach, California
    Hoag Memorial Hospital Presbyterian
Sep 1, 2023

Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)

Recruiting
  • Chronic Hepatitis B
  • VRON-0200-AdC6
  • VRON-0200-AdC7
  • Hong Kong, Hong Kong
  • +1 more
Oct 6, 2023

Adenoviral Keratoconjunctivitis Trial in Pristina (relex smile)

Active, not recruiting
  • Adenoviral Keratoconjunctivitis
  • relex smile
  • Pristina, Kosovo
    Eye Hospital Pristina
Nov 13, 2021

SARS-CoV-2, Covid19 Trial in Brussels (Serological testing)

Recruiting
  • SARS-CoV-2
  • Covid19
  • Serological testing
  • Brussels, Belgium
    UZ Brussel
May 17, 2022

Metastatic Cancer, Epithelial Tumor Trial in United States (NG-641)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641
  • Los Angeles, California
  • +5 more
Jan 16, 2023

Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

Completed
Has Results
  • Breast Neoplasms
  • +3 more
  • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 12, 2022

Secondary Lymphedema Trial in Helsinki, Tampere, Turku (Lymfactin® [1 x 10E10 vp], Lymfactin® [1 x 10E11 vp])

Active, not recruiting
  • Secondary Lymphedema
  • Lymfactin® [1 x 10E10 vp]
  • Lymfactin® [1 x 10E11 vp]
  • Helsinki, Finland
  • +2 more
Mar 16, 2022

Covid19 Trial in Khayelitsha (hAd5-S-Fusion+N-ETSD vaccine)

Recruiting
  • Covid19
  • hAd5-S-Fusion+N-ETSD vaccine
  • Khayelitsha, South Africa
    Khayelitsha Clinical Research Site
Mar 28, 2022

Covid19 Trial in Cypress (VXA-CoV2-1)

Completed
  • Covid19
  • VXA-CoV2-1
  • Cypress, California
    WCCT
Jan 17, 2023

COVID-19 Trial in El Segundo, Newport Beach (hAd5-S-Fusion+N-ETSD vaccine)

Active, not recruiting
  • COVID-19
  • hAd5-S-Fusion+N-ETSD vaccine
  • El Segundo, California
  • +1 more
Mar 28, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Melanoma Trial in Boston (Autologous, lethally irradiated melanoma cells)

Active, not recruiting
  • Melanoma
  • Autologous, lethally irradiated melanoma cells
  • Boston, Massachusetts
  • +1 more
Feb 2, 2022

Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

Recruiting
  • Lynch Syndrome
  • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
  • +2 more
  • Duarte, California
  • +3 more
Nov 22, 2022

Acute Adenoviral Conjunctivitis Trial in Andover, Noida (FST-100, FST-100 (Component #1), FST-100 Vehicle)

Completed
  • Acute Adenoviral Conjunctivitis
  • Andover, Massachusetts
  • +1 more
Jun 23, 2021

Ebola Virus Disease, Marburg Virus Disease Trial in Oklahoma City (cAd3-Marburg, cAd3-EBO-S)

Completed
  • Ebola Virus Disease
  • Marburg Virus Disease
  • cAd3-Marburg
  • cAd3-EBO-S
  • Oklahoma City, Oklahoma
    Oklahoma Blood Institute (OBI)
Aug 2, 2022

Norovirus Infections Trial in Cypress, New Orleans, Austin (VXA-GI.1.NN, Placebo Tablet)

Completed
  • Norovirus Infections
  • VXA-GI.1.NN
  • Placebo Tablet
  • Cypress, California
  • +2 more
Sep 19, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    WCCT Global, Inc.
Sep 19, 2022

Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

Completed
Has Results
  • Glioma
  • +7 more
  • Neural stem cells loaded with an oncolytic adenovirus
  • Duarte, California
  • +1 more
Dec 28, 2022

Acute Adenoviral Conjunctivitis Trial in United States (FST-100 Ophthalmic Suspension, Placebo)

Terminated
  • Acute Adenoviral Conjunctivitis
  • FST-100 Ophthalmic Suspension
  • Placebo
  • Torrance, California
  • +12 more
Aug 22, 2021

HIV Trial (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP, VRC-HIVDNA016-00-VP )

Withdrawn
  • HIV Infections
  • VRC-HIVDNA016-00-VP
  • +3 more
  • (no location specified)
Oct 28, 2021

Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,

Completed
Has Results
  • Prostatic Neoplasms
  • Prostatic Cancer
  • ETBX-071; adenoviral PSA vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2021

COVID-19 Trial in United States (VXA-CoV2-1.1-S, Placebo Tablets)

Recruiting
  • COVID-19
  • Long Beach, California
  • +3 more
Sep 19, 2022

Conjunctivitis, Adenoviral Conjunctivitis Trial in Saint Louis (Betadine 5%, Artificial Tears)

Completed
Has Results
  • Conjunctivitis
  • Adenoviral Conjunctivitis
  • Betadine 5%
  • Artificial Tears
  • Saint Louis, Missouri
    Mary Migneco
Jan 4, 2021